Kamada Ltd. (KMDA)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$7.32
+1.24%
Mkt Cap $417.13M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+104.9%
Consensus $15.00 vs current $7.32